A unique platform for profiling immune-targeting agents

genOway offers the most advanced and comprehensive portfolio of preclinical mouse models for immuno-oncology and immune-therapy research with the necessary intellectual property rights.

More info

Humanized immune checkpoints

ICP Models
  • Fully immunocompetent models featuring humanized immune checkpoints and functional immune system (including interaction with stroma /microenvironment)
  • Biologics’ assessment (including bispecific)
  • Broad spectrum of humanized targets
  • Easy detection of Treg (e.g., GITR/Foxp3-mRFP)
  • Undisclosed targets under validation
  • Intercrosses available upon request

=> Learn more

Immunodeficient model: BRGSF

BRGSF Model
  • The most immunodeficient mouse model: defects in the myeloid and lymphoid compartments (Rag2-/-, IL‑2Rγ-/-, Flk2-/-)
  • Radio-resistant (absence of the SCID mutation on a BALB/c background)
  • Highly permissive to patient-derived xenografts (PDXs) and cell line engraftment (SIRPαNOD)

=> Learn more

Models for PK/PD studies: HSA/hFcRn

HSA/hFcRn
  • Double humanized model displaying physiological relevance due to the autologous HSA/hFcRn interaction
  • Preclinical studies of albumin-based drugs and drugs influenced by reversible binding to HSA
  • Development of albumin-based or Fc-fused drugs
  • Available onto immunodeficient genetic background (Rag1-/-)

=> Learn more

Catalog of immuno-oncology mouse models

Get in touch about

Let us know how we can help

Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe